What is Humanity?
Humanity operates in the burgeoning health-tech industry, offering a mobile application designed to provide users with actionable advice aimed at slowing the aging process and bolstering immune system health. Headquartered in London, United Kingdom, the company is positioned at the intersection of mobile technology and personal wellness, a rapidly expanding market driven by increasing consumer interest in preventative health and longevity solutions.
The company's focus on scientifically-backed advice and personalized guidance aims to empower individuals to take proactive control of their health and well-being.
How much funding has Humanity raised?
Humanity has raised a total of $5M across 2 funding rounds:
Angel/Seed
$2.5M
Angel/Seed
$2.5M
Angel/Seed (2020): $2.5M with participation from One Way Ventures and Esther Dyson
Angel/Seed (2021): $2.5M led by Seedcamp, Esther Dyson, Michael Acton-Smith, Taavet Hinrikus, Robin Thurston, Alex Tew, Breega, Alexander Ljung, One Way Ventures, and 7Percent Ventures
Key Investors in Humanity
One Way Ventures
One Way Ventures is a venture capital firm dedicated to supporting immigrant founders in building high-impact global companies. They invest in exceptional startups and aim to create opportunities for individuals regardless of their birthplace, fostering community and celebrating immigrant entrepreneurship.
Esther Dyson
Esther Dyson is an investor and author focused on technology, health, and emerging markets. She is known for her investments in various sectors, including healthcare and AI, and writes a newsletter discussing her insights on technology and health.
Breega
Breega is a venture capital firm specializing in backing exceptional founders from pre-Seed to Series A+ across Digital, Climate, and Deep Tech sectors. With a team of former founders and operators, they provide financial support, expertise, and tactical insights to help startups scale effectively.
What's next for Humanity?
With the recent major strategic investment, Humanity is poised for accelerated growth and product development. The substantial capital injection suggests a move towards scaling operations, expanding its user base, and potentially enhancing its technological capabilities. This funding round, characterized as enterprise-level, indicates that Humanity has likely achieved significant milestones and is now entering a phase of rapid expansion.
Future developments may include further research into longevity science, integration of advanced AI for personalized health insights, and strategic partnerships to broaden market reach. The company's trajectory points towards solidifying its position as a key player in the digital health and wellness space.
